FOXO TECHNOLOGIES INC. Business Acquisition, Pro Forma Net Income (Loss)
FOXO TECHNOLOGIES INC. (FOXO) reported Business Acquisition, Pro Forma Net Income (Loss) of -$653.95 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. business acquisition, pro forma net income (loss) for the quarter ending 2026-03-31 was -$653.95K.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma net income (loss) for the quarter ending 2025-12-31 was -$9.47M.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma net income (loss) for the quarter ending 2025-09-30 was -$1.92M.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma net income (loss) for the quarter ending 2025-06-30 was -$551.92K.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma net income (loss) for fiscal 2025 was -$12.55M.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma net income (loss) for fiscal 2024 was -$14.58M.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma net income (loss) for fiscal 2023 was -$21.22M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 3 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$653.95K 10-Q · filed 2026-05-15 | -$10.12M derived: sum of 2 quarters · filed 2026-05-15 | -$12.04M derived: sum of 3 quarters · filed 2026-05-15 | -$12.59M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$9.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$11.38M derived: sum of 2 quarters · filed 2026-04-15 | -$11.94M derived: sum of 3 quarters · filed 2026-08-14 | -$12.55M 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | -$1.92M 10-Q · filed 2025-11-10 | -$2.47M derived: sum of 2 quarters · filed 2026-08-14 | -$3.09M 10-Q · filed 2025-11-10 | |||||
| 2025-06-30 | -$551.92K 10-Q · filed 2026-08-14 | -$1.20M 10-Q · filed 2026-08-14 | ||||||
| 2024-12-31 | -$6.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$9.57M derived: sum of 2 quarters · filed 2026-04-15 | -$12.45M derived: sum of 3 quarters · filed 2026-04-15 | -$14.58M 10-K · filed 2026-04-15 | -$14.64M 10-K · filed 2025-04-15 | |||
| 2024-09-30 | -$2.71M 10-Q · filed 2025-11-10 | -$2.79M 10-Q · filed 2024-11-19 | -$5.59M derived: sum of 2 quarters · filed 2025-11-10 | -$7.72M 10-Q · filed 2025-11-10 | -$7.48M 10-Q · filed 2024-11-19 | -$11.19M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | -$2.89M 10-Q · filed 2025-08-19 | -$2.39M 10-Q · filed 2024-08-19 | -$5.03M 10-Q · filed 2025-08-19 | -$4.44M 10-Q · filed 2024-08-19 | -$8.48M derived: sum of 3 quarters · filed 2025-08-19 | -$11.88M derived: sum of 4 quarters · filed 2025-08-19 | ||
| 2024-03-31 | -$2.15M 10-Q/A · filed 2025-08-19 | -$2.07M 10-Q · filed 2024-06-28 | -$5.60M derived: sum of 2 quarters · filed 2025-08-19 | -$9.00M derived: sum of 3 quarters · filed 2025-08-19 | -$20.36M derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2023-12-31 | -$3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$6.85M derived: sum of 2 quarters · filed 2025-04-15 | -$18.21M derived: sum of 3 quarters · filed 2025-04-15 | -$21.22M 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | -$3.40M 10-Q · filed 2024-11-19 | -$14.76M derived: sum of 2 quarters · filed 2024-11-19 | -$17.77M 10-Q · filed 2024-11-19 | |||||
| 2023-06-30 | -$11.36M 10-Q · filed 2024-08-19 | -$19.08M 10-Q · filed 2024-08-19 | ||||||
| 2023-03-31 | -$7.74M 10-Q · filed 2024-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |